Subscribe to RSS

DOI: 10.1055/s-0045-1809356
Embolization of Meningiomas with Ultralow Concentration N-Butyl 2-Cyanoacrylate

Abstract
Objective
Preoperative embolization of meningiomas with n-butyl 2-cyanoacrylate (NBCA) is problematic as its adhesive nature may force termination prior to achieving adequate embolization of intratumoral vessels. Herein, we report the use of ultralow concentration NBCA embolization to address this issue.
Materials and Methods
Seventeen patients with meningiomas underwent embolization with ultralow concentration NBCA. Twenty-four tumor-feeding vessels were embolized with 5% NBCA to allow infiltration of the intratumoral vessels. Overall, this method achieved a reduced operative time and blood loss during the resection as compared with those of the nonembolized group.
Results
Embolization was achieved in all patients at ultralow concentrations. Additionally, 20 vessels (83.3%) were embolized up to the intratumoral level. Warmed 5% NBCA aided in the embolization of intratumoral vessels. Embolization effectively controlled bleeding in all patients, while in 15 patients (88.2%), some form of tumor necrosis or softening was observed, predominantly in the area of dural attachment, demonstrating the efficacy of embolization in tumor removal. No embolization-related complications were observed. The mean operative time for resection was significantly different between the embolization (17 patients) and nonembolization (9 patients) groups (316 vs. 412 minutes, p = 0.0271). In these two groups, the mean blood loss was 349 versus 575 mL, the mean maximum tumor diameter was 56.8 versus 35.4 mm (p = 0.0089), and the mean age was 73.3 versus 72.3 years, respectively, with the significantly larger embolization group having shorter operation time and less blood loss.
Conclusion
Embolization of meningiomas with ultralow concentrations of NBCA can help to reach intratumoral vessels.
Keywords
embolization - intratumoral vessels - meningioma - N-butyl 2-cyanoacrylate - ultralow concentrationEthical Approval
The study protocol was approved by the Ethics Committee of the Kansai Medical University (No. 2023093).
Publication History
Article published online:
02 June 2025
© 2025. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Raper DM, Starke RM, Henderson Jr F. et al. Preoperative embolization of intracranial meningiomas: efficacy, technical considerations, and complications. AJNR Am J Neuroradiol 2014; 35 (09) 1798-1804
- 2 Fukuda K, Higashi T, Okawa M. et al. Preoperative embolization of meningioma with ultra-low concentration n-butyl 2-cyanoacrylate. JNET 2014; 8: 259-265
- 3 Ishihara H, Ishihara S, Niimi J. et al. The safety and efficacy of preoperative embolization of meningioma with N-butyl cyanoacrylate. Interv Neuroradiol 2015; 21 (05) 624-630
- 4 Arai S, Shimizu K, Yamochi T. et al. Preoperative embolization of meningiomas: differences in surgical operability and histopathologic changes between embosphere and n-butyl 2-cyanoacrylate. World Neurosurg 2018; 111: e113-e119
- 5 Borg A, Ekanayake J, Mair R. et al. Preoperative particle and glue embolization of meningiomas: indications, results, and lessons learned from 117 consecutive patients. Neurosurgery 2013; 73 (2, Suppl Operative): ons244-ons251 , discussion ons252
- 6 Manelfe C, Guiraud B, David J. et al. Embolization by catheterization of intracranial meningiomas [in French]. Rev Neurol (Paris) 1973; 128 (05) 339-351
- 7 Shah AH, Patel N, Raper DM. et al. The role of preoperative embolization for intracranial meningiomas. J Neurosurg 2013; 119 (02) 364-372
- 8 Kai Y, Hamada JI, Morioka M. et al. Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas. AJNR Am J Neuroradiol 2006; 27 (05) 1146-1150
- 9 Carli DF, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am J Neuroradiol 2010; 31 (01) 152-154
- 10 Bendszus M, Monoranu CM, Schütz A, Nölte I, Vince GH, Solymosi L. Neurologic complications after particle embolization of intracranial meningiomas. AJNR Am J Neuroradiol 2005; 26 (06) 1413-1419
- 11 Binning MJ, Yashar P, Orion D. et al. Use of the Outreach Distal Access Catheter for microcatheter stabilization during intracranial arteriovenous malformation embolization. AJNR Am J Neuroradiol 2012; 33 (09) E117-E119
- 12 Sadato A, Wakhloo AK, Hopkins LN. Effects of a mixture of a low concentration of n-butylcyanoacrylate and ethiodol on tissue reactions and the permanence of arterial occlusion after embolization. Neurosurgery 2000; 47 (05) 1197-1203 , discussion 1204–1205
- 13 Kominami S, Watanabe A, Suzuki M, Mizunari T, Kobayashi S, Teramoto A. Preoperative embolization of meningiomas with N-butyl cyanoacrylate. Interv Neuroradiol 2012; 18 (02) 133-139
- 14 Gounis MJ, Lieber BB, Wakhloo AK, Siekmann R, Hopkins LN. Effect of glacial acetic acid and ethiodized oil concentration on embolization with N-butyl 2-cyanoacrylate: an in vivo investigation. AJNR Am J Neuroradiol 2002; 23 (06) 938-944
- 15 Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993; 78 (01) 60-69
- 16 Stoesslein F, Ditscherlein G, Romaniuk PA. Experimental studies on new liquid embolization mixtures (histoacryl-lipiodol, histoacryl-panthopaque). Cardiovasc Intervent Radiol 1982; 5 (05) 264-267
- 17 Kora S, Urakawa H, Mitsufuji T. et al. Warming effect on miriplatin-lipiodol suspension for potential use as a chemotherapeutic agent for transarterial chemoembolization of hepatocellular carcinoma: in vitro study. Hepatol Res 2013; 43 (10) 1100-1104
- 18 Omura N, Hiramatsu R, Yagi R. et al. Comparison of outcomes with/without preoperative embolization for meningiomas with diluted N-butyl-2-cyanoacrylate. Clin Neurol Neurosurg 2024; 238: 108178
- 19 Yamamoto T, Ohshima T, Nishihori M. et al. Preoperative embolization of meningiomas with low-concentration n-butyl cyanoacrylate. Nagoya J Med Sci 2015; 77 (03) 347-353
- 20 n-BCA Trail Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002; 23 (05) 748-755
- 21 Sughrue ME, Kane AJ, Shangari G. et al. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 2010; 113 (05) 1029-1035
- 22 Akimoto T, Ohtake M, Miyake S. et al. Preoperative tumor embolization prolongs time to recurrence of meningiomas: a retrospective propensity-matched analysis. J Neurointerv Surg 2023; 15 (08) 814-820
- 23 Ohnishi H, Miyachi S, Murao K. et al. Infiltrated embolization of meningioma with dilute cyanoacrylate glue. Neurol Med Chir (Tokyo) 2017; 57 (01) 44-50
- 24 Nakajima N, Fukuda H, Adachi H. et al. Long-term volume reduction effects of endovascular embolization for intracranial meningioma: preliminary experience of 5 cases. World Neurosurg 2017; 105: 591-598